Description Iambic is disrupting the therapeutics landscape with its cutting-edge generative AI drug discovery platform. We have assembled a world-class team that unites pioneering AI experts and seasoned drug hunters with strong track records of success in delivering clinically validated breakthrough treatments. The Iambic platform has been demonstrated to deliver high-quality, differentiated drugs to clinics with unprecedented speed and across multiple target classes and mechanisms of action. We are focused on the advancement of our internal pipeline of clinical assets to address urgent unmet patient needs in oncology and other therapeutic areas. Iambic's’ team currently consists of fifty in the US and ten globally.